Sean Moran
2017 - Corbus Pharmaceuticals Holdings
In 2017, Sean Moran earned a total compensation of $1.2M as Chief Financial Officer at Corbus Pharmaceuticals Holdings, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $140,700 |
|---|---|
| Option Awards | $765,210 |
| Salary | $335,000 |
| Total | $1,240,910 |
Moran received $765.2K in option awards, accounting for 62% of the total pay in 2017.
Moran also received $140.7K in bonus and $335K in salary.
Rankings
In 2017, Sean Moran's compensation ranked 7,943rd out of 14,666 executives tracked by ExecPay. In other words, Moran earned more than 45.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,943 out of 14,666 | 46th |
Division Manufacturing | 2,979 out of 5,768 | 48th |
Major group Chemicals And Allied Products | 975 out of 2,074 | 53rd |
Industry group Drugs | 761 out of 1,730 | 56th |
Industry Pharmaceutical Preparations | 598 out of 1,329 | 55th |
Source: SEC filing on April 13, 2018.
Moran's colleagues
We found three more compensation records of executives who worked with Sean Moran at Corbus Pharmaceuticals Holdings in 2017.